Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Pustular Psoriasis (GPP)”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 320
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, School of Medicine, Zhejiang University 135
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing

The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49
Testing effectiveness (Phase 2)Study completedNCT03782792
What this trial is testing

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 53
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Large-scale testing (Phase 3)Study completedNCT05200247
What this trial is testing

An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 11
Large-scale testing (Phase 3)Study completedNCT03022045
What this trial is testing

Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Psoriasis
AbbVie 18
Not applicableStudy completedNCT07428915
What this trial is testing

Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists

Who this might be right for
Pustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more
AI Labs Group S.L 15
Testing effectiveness (Phase 2)Looking for participantsNCT07013201
What this trial is testing

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
LEO Pharma 135
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Large-scale testing (Phase 3)Ended earlyNCT05366855
What this trial is testing

Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT05239039
What this trial is testing

An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 39
Not applicableNot Yet RecruitingNCT07448428
What this trial is testing

Generalized Pustular Psoriasis Registry in Costa Rica

Who this might be right for
Generalized Pustular PsoriasisGeneralized Pustular Psoriasis (GPP)
Caja Costarricense de Seguro Social 50
Not applicableLooking for participantsNCT06100991
What this trial is testing

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

Who this might be right for
Generalized Pustular Psoriasis
CorEvitas 200
Testing effectiveness (Phase 2)Study completedNCT04399837
What this trial is testing

Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 123
Not applicableLooking for participantsNCT05994976
What this trial is testing

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Who this might be right for
AcneAtopic DermatitisChronic Hand Eczema+3 more
Innovaderm Research Inc. 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06295692
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Janssen Pharmaceutical K.K. 19
Large-scale testing (Phase 3)Study completedNCT05352893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT03135548
What this trial is testing

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Who this might be right for
Psoriasis
Boehringer Ingelheim 59
Load More Results